Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Par Pharmaceutical Companies, Inc. (PRX) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Par Pharmaceutical Companies, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 878088.
Total stock buying since 2011: $262,360.
Total stock sales since 2011: $16,198,328.
Total stock option exercises since 2011: $4,979,018.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2012 | 0 | $0 | 15,000 | $555,592 | 15,000 | $431,850 |
| 2011 | 10,000 | $262,360 | 482,292 | $15,642,736 | 282,193 | $4,547,168 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2012-03 | 0 | $0 | 15,000 | $555,592 | 15,000 | $431,850 |
| 2011-12 | 0 | $0 | 5,000 | $162,539 | 5,000 | $149,500 |
| 2011-09 | 10,000 | $262,360 | 0 | $0 | 0 | $0 |
| 2011-05 | 0 | $0 | 198,860 | $6,912,020 | 160,858 | $1,958,822 |
| 2011-03 | 0 | $0 | 278,432 | $8,568,177 | 116,335 | $2,438,846 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-03-19 | Knight Peter S (Director) | Sale | 7,500 | 37.03 | 277,717 |
| 2012-03-19 | Knight Peter S (Director) | Option Ex | 7,500 | 28.79 | 215,925 |
| 2012-03-19 | Nordmann Ronald M (Director) | Sale | 7,500 | 37.05 | 277,875 |
| 2012-03-19 | Nordmann Ronald M (Director) | Option Ex | 7,500 | 28.79 | 215,925 |
| 2011-12-15 | Knight Peter S (Director) | Sale | 2,500 | 32.52 | 81,287 |
| 2011-12-15 | Knight Peter S (Director) | Option Ex | 2,500 | 29.90 | 74,750 |
| 2011-12-15 | Nordmann Ronald M (Director) | Sale | 2,500 | 32.50 | 81,252 |
| 2011-12-15 | Nordmann Ronald M (Director) | Option Ex | 2,500 | 29.90 | 74,750 |
| 2011-09-06 | Tropiano Michael A (EVP & CFO) | Buy | 2,000 | 27.50 | 55,000 |
| 2011-09-06 | Lepore Patrick G (Chairman, President & CEO) | Buy | 8,000 | 25.92 | 207,360 |
| 2011-05-10 | Haughey Thomas (EVP, CAO, General Counsel) | Sale | 26,800 | 35.58 | 953,410 |
| 2011-05-10 | Haughey Thomas (EVP, CAO, General Counsel) | Option Ex | 26,800 | 13.06 | 350,008 |
| 2011-05-09 | Haughey Thomas (EVP, CAO, General Counsel) | Sale | 106,593 | 34.87 | 3,717,217 |
| 2011-05-09 | Haughey Thomas (EVP, CAO, General Counsel) | Option Ex | 68,591 | 10.99 | 753,815 |
| 2011-05-09 | Lepore Patrick G (Chairman, President & CEO) | Sale | 65,467 | 34.24 | 2,241,393 |
| 2011-05-09 | Lepore Patrick G (Chairman, President & CEO) | Option Ex | 65,467 | 13.06 | 854,999 |
| 2011-03-08 | Campanelli Paul (EVP, Pres-Par Pharmaceutical) | Sale | 52,070 | 30.58 | 1,596,758 |
| 2011-03-07 | Campanelli Paul (EVP, Pres-Par Pharmaceutical) | Sale | 116,365 | 30.93 | 3,585,877 |
| 2011-03-07 | Campanelli Paul (EVP, Pres-Par Pharmaceutical) | Option Ex | 116,335 | 20.96 | 2,438,846 |
Insider trading activities including stock purchases, stock sales, and option exercises of PRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Par Pharmaceutical Companies, Inc. (symbol PRX, CIK number 878088) see the Securities and Exchange Commission (SEC) website.